About
John Scribner represents clients on their most significant antitrust merger matters, playing a lead role in obtaining FTC and DOJ regulatory approval for transactions across numerous industries, with particular experience in the high-tech and pharmaceutical sectors.
Practice area
Antitrust
Office
Expertise
High-TechPharmaceutical